ResearcherBellvitge University HospitalNo recent work listed

Emilio Ramos Rubio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2688-0101; OpenAlex author ID A5006862583. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. Last author DOI 10.1016/j.ciresp.2017.07.008 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Juan Fabregat · 1 shared paper, 2017 · strength 0.06
- Paper Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. DOI 10.1016/j.ciresp.2017.07.008 ↗
Helena Verdaguer · 1 shared paper, 2017 · strength 0.06
- Paper Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. DOI 10.1016/j.ciresp.2017.07.008 ↗
Berta Laquente · 1 shared paper, 2017 · strength 0.06
- Paper Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. DOI 10.1016/j.ciresp.2017.07.008 ↗
Lluís Secanella · 1 shared paper, 2017 · strength 0.06
- Paper Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. DOI 10.1016/j.ciresp.2017.07.008 ↗
Juli Busquets · 1 shared paper, 2017 · strength 0.06
- Paper Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. DOI 10.1016/j.ciresp.2017.07.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.